VIENNA – Providing firm evidence that new imaging technology is sustainable and has a positive and meaningful impact on radiology workflow are the key priorities of vendors in Europe and beyond, according to market analyst and regular AuntMinnieEurope.com columnist Steve Holloway.
Holloway, who is managing director of Signify Research in the U.K., discussed some of the surprises that his team of seven analysts found in the ECR 2024 technical exhibition. In a video interview, he also addressed the main market trends in Europe -- and even gives a hot equine tip for the upcoming Cheltenham Festival of horseracing held over jumps in south-west England.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
